13F-HR filed by Opti Capital Management, LP
Opti Capital Management, LP filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-15, with 31 holding rows worth $488,056,000.
- Accession
- 0000919574-20-003571
- Filer
- CIK 1738654
- Filed
- 2020-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2020
A holdings report, 31 entries on the cover page, a total value of $488,056,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $488,056,000 with VALUE read as thousands by filing date, 13F file number 028-19379. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TERADYNE INC | 880770AG7 | NOTE | 35,939 | $64,486,000 | thousands by filing date | principal |
| COUPA SOFTWARE INC | 22266LAB2 | NOTE 0.375% 1/1 | 16,380 | $51,497,000 | thousands by filing date | principal |
| MANDIANT INC | 31816QAD3 | NOTE 1.625% 6/0 | 52,692 | $48,475,000 | thousands by filing date | principal |
| VERINT SYS INC | 92343XAA8 | NOTE 1.500% 6/0 | 47,193 | $46,443,000 | thousands by filing date | principal |
| JAZZ INVESTMENTS I LTD | 472145AB7 | NOTE 1.875% 8/1 | 35,330 | $34,203,000 | thousands by filing date | principal |
| SUPERNUS PHARMACEUTICALS | 868459AD0 | BOND | 41,026 | $33,718,000 | thousands by filing date | principal |
| ALLSCRIPTS HEALTHCARE SOLUTN | 01988PAD0 | NOTE 1.250% 7/0 | 29,385 | $28,798,000 | thousands by filing date | principal |
| WORKDAY INC | 98138HAD3 | NOTE 1.500% 7/1 | 15,500 | $24,932,000 | thousands by filing date | principal |
| NUTANIX INC | 67059NAB4 | NOTE 1/1 | 24,339 | $19,973,000 | thousands by filing date | principal |
| TWITTER INC | 90184LAD4 | NOTE 1.000% 9/1 | 18,192 | $17,373,000 | thousands by filing date | principal |
| J2 GLOBAL INC | 48123VAC6 | NOTE 3.250% 6/1 | 10,871 | $13,222,000 | thousands by filing date | principal |
| 8X8 INC NEW | 282914AB6 | BOND | 13,450 | $11,562,000 | thousands by filing date | principal |
| PACIRA BIOSCIENCES | 695127AD2 | NOTE 2.375% 4/0 | 10,545 | $10,222,000 | thousands by filing date | principal |
| TESLA INC | 88160RAG6 | NOTE 2.000% 5/1 | 5,000 | $9,175,000 | thousands by filing date | principal |
| Omeros Corp | 682143AE2 | NOTE 6.250%11/1 | 10,000 | $9,151,000 | thousands by filing date | principal |
| INFINERA CORP | 45667GAC7 | BOND | 10,500 | $9,096,000 | thousands by filing date | principal |
| RAPID7 INC | 753422AB0 | NOTE | 6,500 | $7,926,000 | thousands by filing date | principal |
| CYTOKINETICS INC | 23282WAA8 | NOTE 4.000%11/1 | 5,000 | $6,730,000 | thousands by filing date | principal |
| NEW RELIC INC | 64829BAB6 | NOTE 0.500% 5/0 | 6,297 | $5,383,000 | thousands by filing date | principal |
| THERAVANCE INC | 88338TAB0 | CORPORATE OBLIG | 5,200 | $4,850,000 | thousands by filing date | principal |
| INTERCEPT PHARMACEUTICALS IN | 45845PAA6 | NOTE 3.250% 7/0 | 5,500 | $4,561,000 | thousands by filing date | principal |
| NUVASIVE INC | 670704AG0 | NOTE 2.250% 3/1 | 4,283 | $4,482,000 | thousands by filing date | principal |
| ZENDESK INC | 98936JAB7 | NOTE 0.250% 3/1 | 3,750 | $4,446,000 | thousands by filing date | principal |
| DOCUSIGN INC | 256163AB2 | NOTE 0.500% 9/1 | 2,500 | $3,534,000 | thousands by filing date | principal |
| ON SEMICONDUCTOR CORP | 682189AK1 | NOTE 1.000%12/0 | 3,500 | $3,489,000 | thousands by filing date | principal |
| CAESARS ENTMT CORP | 127686AA1 | NOTE | 2,500 | $2,695,000 | thousands by filing date | principal |
| RAMBUS INC DEL | 750917AG1 | NOTE 1.375% 2/0 | 2,500 | $2,429,000 | thousands by filing date | principal |
| ZILLOW GROUP INC | 98954MAC5 | NOTE 1.500% 7/0 | 2,500 | $2,110,000 | thousands by filing date | principal |
| CREE INC | 225447AB7 | NOTE 0.875% 9/0 | 1,500 | $1,392,000 | thousands by filing date | principal |
| ISIS PHARMACEUTICALS INC DEL | 464337AJ3 | NOTE 1.000%11/1 | 1,000 | $1,024,000 | thousands by filing date | principal |
| OPKO HEALTH INC | 68375NAD5 | NOTE 4.500% 2/1 | 1,000 | $679,000 | thousands by filing date | principal |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-20-003571 | this filing | 2020-05-15 | acceptance time not in the bulk data set |